Published in Gene Therapy Weekly, March 16th, 2006
"The holy grail of cancer therapy is to identify and exploit genetic elements and signal transduction pathways capable of selectively destroying tumor cells without eliciting harmful effects in normal cells or tissues," wrote P.B. Fisher and colleagues, Columbia University.
"To achieve this objective, subtraction hybridization was combined with a differentiation therapy model of cancer in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.